Case Study
Virtual Screening Service

Inquiry
Virtual Screening Service

Virtual Screening Services for Drug Discovery

High-Throughput In Silico Screening to Accelerate Hit Identification. We combine structure-based and ligand-based strategies to identify potential drug candidates efficiently.

Request a Quote View Service List
Virtual Screening Background
# Virtual Screening # Hit Identification # In Silico Screening # Structure-Based Design # Ligand-Based Design # High-Throughput Screening # GPCR # Kinase Inhibitors # Molecular Docking # Pharmacophore Modeling # Virtual Screening # Hit Identification # In Silico Screening # Structure-Based Design # Ligand-Based Design # High-Throughput Screening # GPCR # Kinase Inhibitors # Molecular Docking # Pharmacophore Modeling

What Is Virtual Screening in Drug Discovery?

Virtual screening (VS) is a computational technique used in drug discovery to search libraries of small molecules in order to identify those structures which are most likely to bind to a drug target, typically a protein receptor or enzyme.

Compared to traditional experimental High-Throughput Screening (HTS), in silico virtual screening offers a cost-effective and rapid alternative for early-stage drug discovery.

  • Accelerate the hit-to-lead process significantly.
  • Reduce the cost of experimental screening by filtering libraries.
  • Applicable to both known and unknown target structures.

Speak to an Expert

Virtual Screening Visualization
Areas of Expertise

Applications of Virtual Screening Services

Our computational screening solutions cover a wide range of therapeutic targets and discovery scenarios.

Kinase Inhibitors

Kinase Inhibitors

Targeting signaling pathways.

  • Screening for ATP-competitive inhibitors.
  • Allosteric modulator identification.
  • Selectivity profiling against kinase panels.
GPCR Drug Discovery

GPCR Drug Discovery

Addressing complex membrane proteins.

  • Homology modeling for targets without crystal structures.
  • Ligand-based screening for orphan GPCRs.
  • Bias signaling pathway analysis.
PPI Inhibitors

PPI Inhibitors

Protein-Protein Interaction modulation.

  • Targeting large, flat binding interfaces.
  • Peptide and peptidomimetic screening.
  • Fragment-based screening for hot-spot targeting.
Antiviral Discovery

Antiviral Drug Discovery

Combatting infectious diseases.

  • Screening against viral proteases and polymerases.
  • Drug repurposing libraries for rapid response.
  • Nucleoside analog screening.

Explore Your Target

Our Virtual Screening Solutions

Target-focused computational strategies designed to address specific drug discovery challenges.

Small Molecule Drug Virtual Screening

High-throughput identification of potent inhibitors. We optimize hit rates for standard binding pockets using advanced algorithms.

Learn more

Protein Drug Virtual Screening

Specialized screening for peptide therapeutics and biologics, accounting for flexibility and large surface interactions.

Learn more

Compound Library Design

Curate focused libraries tailored to your target. We filter for drug-likeness and diversity to maximize efficiency.

Learn more

Multiple-target Virtual Screening

Address polypharmacology and repurposing by screening compounds against multiple targets simultaneously.

Learn more

Get a Customized Solution Quote

Screening Services
Available Now

Ready to screen?

Discover the perfect library for your target. Our catalog covers comprehensive specifications for Bioactive, Natural Product, and Fragment libraries tailored for drug discovery.

Download PDF Brochure

Our Virtual Screening Service Capabilities

We employ advanced algorithms and high-performance computing to offer comprehensive computational screening services. Select a service below to learn more.

Inverse Virtual Screening Service

Target Identification & Drug Repositioning
Identify potential protein targets for a given small molecule with our advanced "Target Fishing" approach. Our inverse screening (Reverse Docking) platform screens your compound against a vast database of the druggable proteome.

This service is critical for drug repositioning, elucidating the mechanism of action for phenotypic hits, and predicting potential toxicity by identifying off-target interactions early in the discovery process.

Read More

Ligand-based Virtual Screening (LBVS)

Screening Without Structure
Ideally suited for targets where the crystal structure is unavailable or highly flexible. We leverage the chemical features of known active ligands to identify novel hits.

By utilizing shape similarity search, molecular fingerprinting, and advanced QSAR modeling, we can efficiently enrich compound libraries with scaffolds that possess high structural or electrostatic similarity to your reference compounds.

Read More

Structure-based Virtual Screening (SBVS)

High-Precision Molecular Docking
When the 3D structure of the target is available, our SBVS service provides the most direct method for hit identification. We utilize high-performance docking algorithms to predict the preferred binding orientation and affinity of millions of small molecules.

Our workflow includes ensemble docking to account for protein flexibility and consensus scoring to minimize false positives, delivering a high-quality list of candidates for experimental testing.

Read More

Fragment-based Virtual Screening

Exploring Chemical Space Efficiently
Screening low molecular weight compounds (fragments) allows for a more efficient exploration of chemical space compared to HTS. This method is particularly effective for "undruggable" or challenging targets.

We identify weak but specific binders with high ligand efficiency, which can then be grown or linked into potent lead compounds using structural guidance, offering a robust starting point for lead generation.

Read More

Pharmacophore-based Virtual Screening

Scaffold Hopping & abstract Design
We construct precise 3D pharmacophore models defined by the spatial arrangement of essential features (hydrogen bond donors/acceptors, hydrophobic regions) required for binding.

This abstract method is powerful for "scaffold hopping," allowing us to identify structurally diverse chemotypes that share the same biological activity profile but possess improved physicochemical properties or novel intellectual property positions.

Read More

Discuss Your Project Requirements

Compound Databases Available for Screening

Access our diverse and high-quality compound libraries, ranging from bioactive molecules to fragment-based collections.

Library Category Available Collections & Specifications
Bioactive Compound Libraries
Bioactive Compound Library Drug Repurposing Compound Library Featured Novel Bioactive Compound Library Disease-Specific Collections Target-Focused Libraries (GPCR, Kinase, etc.) Approved Drug Library
Natural Product Libraries
Disease-Functional Natural Products Activity-classified Natural Product Library Structure-classified Natural Product Library Natural Product Derivatives Libraries High-Throughput Screening (HTS) Natural Products
Drug-Like Compound Libraries
High-Diversity Drug-Like Library CNS-Penetrant Library Macrocyclic Compounds Potential Disease Targets Pathway-Focused Screening Sets
Fragment Libraries
General Fragment Library (Ro3 Compliant) Drug-Fragment Library High Solubility 3D Diversity Fragment Library Featured Fragments High Solubility Micro Fragment Library Carboxylic Acid Fragment Library Mini Electrophilic Heterocyclic Fragment Library

Inquire About Specific Libraries

Virtual Screening Workflow and Methodology

A systematic in silico screening workflow ensures the efficient identification of high-quality hits from compound libraries.

1. Library Preparation

Curation of small molecule libraries (e.g., ZINC, ChEMBL, or custom libraries). Filtering for drug-like properties (Lipinski's Rule of 5) and ADMET criteria.

2. Target Analysis

Binding pocket identification and preparation. We analyze the receptor for druggability and flexibility to ensure accurate docking.

3. Docking & Scoring

High-throughput docking of millions of compounds. We use advanced scoring functions to rank compounds based on predicted binding affinity.

4. Hit Selection

Post-screening analysis including visual inspection of binding modes and hit prioritization for experimental validation.

Start Your Project

Why Choose Our Virtual Screening Services?

We provide accurate, reliable, and scalable in silico screening solutions tailored to your drug discovery needs.

Experienced Computational Biologists

Our team consists of PhD-level experts with extensive experience in structure-based drug design, molecular dynamics, and chemoinformatics, ensuring professional handling of your project.

High-Performance Computing

We leverage powerful GPU clusters and optimized algorithms to screen millions of compounds in a fraction of the time required by traditional methods, without compromising accuracy.

Advanced Scoring & Analysis

Beyond simple docking scores, we employ consensus scoring, binding free energy calculations (MM/PBSA, FEP), and visual inspection of binding modes to prioritize the most promising hits.

Lead Optimization Support

Our service doesn't end at hit identification. We provide post-screening support including molecular dynamics simulation, ADMET prediction, and lead optimization suggestions.

Connect with Our Experts Today

Deliverables from Virtual Screening Projects

We provide comprehensive data and reports to facilitate your downstream experimental assays.

  • Ranked Compound List: A prioritized list of hits with docking scores and calculated binding energies.
  • Docking Poses: 3D coordinates of the predicted binding modes for the top hits (PDB/SDF format).
  • Screening Report: A detailed report describing the methodology, target preparation, library details, and analysis of top interactions.
  • Interaction Analysis: 2D and 3D visualization of key protein-ligand interactions.

Virtual Screening Service FAQs

Ask a Question

Request a Quote for Virtual Screening Services

Contact our computational drug discovery experts today to start your virtual screening project.

x
Need help getting the data you need?

Talk to our technical team about your project!

I Want To Talk
Copyright © CD ComputaBio. All Rights Reserved.
Top